Ascendis Pharma A/S - ADR Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.65575
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, a...

195.58 -2.09 (-1.06%)

New 52W High in past week

227.3K

XNAS Volume

XNAS 12 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.0 / 100

Technically Moderately Bullish

61.2 / 100

250

1Yr Price target upside is 28%

15 analysts

Ascendis Pharma AS ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..